← Back
$ELVN All transactions

Enliven Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$201K

Shares

8,015

Price

$25

Filed

Jan 12

Insider

Name

Heyman Richard A.

Title

CIK

0001584759

Roles

Director

Transaction Details

Transaction Date

2026-01-08

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

29,392

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2024 by RAHD Capital LLC, for which the Reporting Person serves as a managing member. | The shares are held of record by RAHD Capital LLC. | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2024 by the Reporting Person and by Richard A. Heyman and Anne E. Daigle Trust, UAD 01/01/1995, as amended November 1, 2016, for which the Reporting Person serves as trustee (the "Heyman Daigle Trust"). | This transaction was executed in multiple trades at prices ranging from $25.00 to $25.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. | The shares are held of record by the Heyman Daigle Trust. | This transaction was executed in multiple trades at prices ranging from $25.00 to $25.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Filing Info

Accession No.

0001584759-26-000004

Form Type

4

Issuer CIK

0001672619

Heyman Richard A.'s History

Date Ticker Type Value
2026-02-17 ELVN $32K
2026-02-12 ELVN A $0
2026-01-20 ELVN $14K
2026-01-20 ELVN $19K
2026-01-16 ORIC $42K
2026-01-16 ORIC $38K
2026-01-09 ELVN $107K
2026-01-08 ELVN $40K
2026-01-08 ELVN $201K
2026-01-02 ORIC A $0

Other Insiders at ELVN (90d)

Insider Bought Sold Last
Garland J. Scott 2026-02-12
Kunkel Lori Anne 2026-02-12
Gupta Rishi 2026-02-12
Heyman Richard A. $32K 2026-02-17
Bauer Jake 2026-02-12
Collins Helen Louise
CHIEF MEDICAL OFFICER
$4.2M 2026-04-17
Ballal Rahul D. 2026-02-12
Derynck Mika K 2026-02-12
Hohl Benjamin
CHIEF FINANCIAL OFFICER
$296K 2026-03-06
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
$145K 2026-02-12
Patel Anish
CHIEF OPERATING OFFICER
2026-02-12